INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 20 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2017. The put-call ratio across all filers is 3.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 2,000 | +81.8% | 0.00% | – |
Q2 2017 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $3,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 72,787 | $219,000 | 0.22% |
Tekla Capital Management LLC | 1,404,000 | $4,226,000 | 0.20% |
FIRST MIDWEST BANK TRUST DIVISION | 49,372 | $149,000 | 0.02% |
Tower Research Capital LLC (TRC) | 13,287 | $40,000 | 0.00% |
A.R.T. Advisors, LLC | 17,910 | $53,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 12,000 | $36,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 25 | $0 | 0.00% |
AMERIPRISE FINANCIAL INC | 30,000 | $90,000 | 0.00% |
1832 Asset Management L.P. | 12 | $0 | 0.00% |
DEUTSCHE BANK AG\ | 192,676 | $579,000 | 0.00% |